You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Fluorescence-Guided Surgery
|
|---|---|
| Published in |
Frontiers in oncology, December 2017
|
| DOI | 10.3389/fonc.2017.00314 |
| Pubmed ID | |
| Authors |
Tadanobu Nagaya, Yu A. Nakamura, Peter L. Choyke, Hisataka Kobayashi |
| Abstract |
Surgical resection of cancer remains an important treatment modality. Despite advances in preoperative imaging, surgery itself is primarily guided by the surgeon's ability to locate pathology with conventional white light imaging. Fluorescence-guided surgery (FGS) can be used to define tumor location and margins during the procedure. Intraoperative visualization of tumors may not only allow more complete resections but also improve safety by avoiding unnecessary damage to normal tissue which can also reduce operative time and decrease the need for second-look surgeries. A number of new FGS imaging probes have recently been developed, complementing a small but useful number of existing probes. In this review, we describe current and new fluorescent probes that may assist FGS. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Argentina | 1 | 33% |
| Switzerland | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 316 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 316 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 55 | 17% |
| Student > Bachelor | 45 | 14% |
| Student > Master | 37 | 12% |
| Researcher | 31 | 10% |
| Student > Doctoral Student | 20 | 6% |
| Other | 39 | 12% |
| Unknown | 89 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 53 | 17% |
| Chemistry | 35 | 11% |
| Biochemistry, Genetics and Molecular Biology | 30 | 9% |
| Engineering | 28 | 9% |
| Agricultural and Biological Sciences | 11 | 3% |
| Other | 45 | 14% |
| Unknown | 114 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 May 2023.
All research outputs
#1,635,119
of 25,382,440 outputs
Outputs from Frontiers in oncology
#307
of 22,428 outputs
Outputs of similar age
#36,584
of 447,848 outputs
Outputs of similar age from Frontiers in oncology
#6
of 82 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,428 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,848 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.